Pfizer Inc.: Why is PFE Stock Going Nuts Today?
Pfizer Stock: Benefiting From Trump Healthcare Policies
Pfizer Inc. (NYSE:PFE) stock is one of the biggest gainers from Donald Trump’s surprise victory in the U.S. presidential race on speculation that his term will be less hostile to pharmaceutical and biotech companies.
Pfizer stock surged 9.4% during early trading in New York, riding on the positive wave for the biotech sector, while overall market sentiment remained negative. PFE stock rose to about $33.00, its highest level since September 26.
The big impetus for Pfizer stock is coming from the policy direction on healthcare reforms that Donald Trump promised to take if he won the election. That means immediate repealing of Obamacare and less regulations for drug prices.
In contrast to Trump’s policy, Hillary Clinton has favored more regulations for drug pricing. In August, she called the skyrocketing price of the EpiPen, “the latest troubling example of a company taking advantage of its consumers.’’ That statement from Clinton sent stock prices of drugmakers tumbling that day. (Source: “Hillary Clinton blasts ‘outrageous’ explosion in EpiPen pricing, and drugmakers’ stocks are feeling the heat,” Business Insider, August 24, 2016.)
In his healthcare reform agenda, Trump has clearly mentioned that he will work with Congress to do away with “Obamacare,” which was a key policy initiative of President Obama during his eight-year tenure.
“On day one of the Trump Administration, we will ask Congress to immediately deliver a full repeal of Obamacare,’’ reads the healthcare reform agenda on Trump’s web site. “By following free market principles and working together to create sound public policy that will broaden healthcare access, make healthcare more affordable and improve the quality of the care available to all Americans.” (Source: “Healthcare Reform To Make America Great Again,” Donald Trump web site, last accessed November 9, 2016.)
The news of Trump’s win and the repeal of a California ballot measure that would have limited prices on several prescriptions has led to a rise in shares in the drug industry. The NASDAQ biotechnology index enjoyed an eight-percent increase on Wednesday morning. (Source: “Drug stocks rip higher after Trump’s upset victory signals easing pressure on prices,” Business Insider, November 9, 2016.)
Final Word of PFE Stock
Changing fortunes for Pfizer stock may be a good opportunity for income investors who are seeking to add a global pharma name with a great dividend yield in their portfolio.
PFE stock is one of the top dividend companies when compared to the average dividend yield available in the market. Since the second quarter of 2011, Pfizer’s dividend has gone from$0.20 per share to $0.30 a share, a 50% increase. Pfizer Inc. currently yields 3.7%.
Dear Reader: There is no magic formula to getting rich. Success in investment vehicles with the best prospects for price appreciation can only be achieved through proper and rigorous research and analysis. We are 100% independent in that we are not affiliated with any bank or brokerage house. Information contained herein, while believed to be correct, is not guaranteed as accurate. Warning: Investing often involves high risks and you can lose a lot of money. Please do not invest with money you cannot afford to lose. The opinions in this content are just that, opinions of the authors. We are a publishing company and the opinions, comments, stories, reports, advertisements and articles we publish are for informational and educational purposes only; nothing herein should be considered personalized investment advice. Before you make any investment, check with your investment professional (advisor). We urge our readers to review the financial statements and prospectus of any company they are interested in. We are not responsible for any damages or losses arising from the use of any information herein. Past performance is not a guarantee of future results. All registered trademarks are the property of their respective owners
Sign up to receive our FREE Income Investors newsletter along with our special offers and get our FREE report:
5 Dividend Stocks to Own Forever
This is an entirely free service. No credit card required. You can opt-out at anytime.
We hate spam as much as you do.